Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Research
January 29, 2026
Research
January 28, 2026
Research
January 28, 2026
Research
January 22, 2026
Research
January 21, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community